{"name":"Australian and New Zealand Urogenital and Prostate Cancer Trials Group","slug":"australian-and-new-zealand-urogenital-and-prostate-cancer-trials-group","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxPS3ZxZFNXSXRRckZtYlVMV0lPYkJWS3hQb1FnUkYzUFFrNFdBaU9hSlU2VE42TGtJa1V4dy1qUjdRdDl6cTFUVHBfaHBxRUlpTVktRk9saDZtNnQ5Q0wzeDEwN0hkdjFFa3dwWU1RRW44cXZhaVpBZmhLcnZQdnJ5dk90QWM5NFRXVExTQ0NqLU5FTHVFQlNOcUhaYXhrMXhSWGNad1UzM082MFBzeUZ5U2lUY2p1MmM1VnFHN1NsWFN6YVlxVDdyNXJHcjdUNWp4QXRuVmxLVFBWcDhyS29oWTVJZzBzMTlxY3JEc3hhSQ?oc=5","date":"2026-02-01","type":"regulatory","source":"Journal of Hematology Oncology Pharmacy","summary":"Comparison of Second-Generation Antiandrogens for the Treatment of Prostate Cancer - Journal of Hematology Oncology Pharmacy","headline":"Comparison of Second-Generation Antiandrogens for the Treatment of Prostate Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTE15eU1oWVUyZS1YRlFxWk9rSkZCbnZ2X0diNTBTWjZxLUxZM0dTSk8yaVdicmpwY3hodG00SjJjcVlzRnF2OFI1b2pMTXR3SHdZTTU4MDVYUmE?oc=5","date":"2026-01-14","type":"pipeline","source":"Oncodaily","summary":"ANZUP 2026 Annual Scientific Meeting - Oncodaily","headline":"ANZUP 2026 Annual Scientific Meeting","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE90MmR4OWd4UkJiYlpVOFFEY2Z2WjlyeUFjbGU3NEpzbGE4eFM5MU45S1lxZjNldXNBTGtQLUc2YWlsNlRuWTg3MnRlR3JWeEg5Zkt4TVh3UFZibjEwTUY0?oc=5","date":"2025-12-17","type":"pipeline","source":"Nature","summary":"Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer - Nature","headline":"Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQME9ZVGtqdFJWUENUY3BSUW9Sb2l0cGU1dXF6elZ2aTQ0dm1lU3IxYkp2bUhYcGpfZVNRTlk0aGQ1aERDbklFSDlKaTNCVkxEVW85RFFEZWJJaWthaTRLeDBTem1yUXlPeTRUVU01ejlsaXEtY080TFlZbWhuY2xhQ09GcGswSHdGNUNZeWZERWNhMHozM3BLSQ?oc=5","date":"2025-10-10","type":"trial","source":"Times Higher Education","summary":"Australia is ready to take on the US’ defunded clinical trials - Times Higher Education","headline":"Australia is ready to take on the US’ defunded clinical trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNa3VUN2RORk5RSk1raURHXy1NX21uOVdOMW1BbFpFYXVuOEZ0UEIxRk1IOGhweWExeHhqZXhERWp2NVNCekZ0dy1VeE04UnpMaHdRLXlqN3Zrd0NjSC1jNWRDcGMyVWNKSW1vaVZjaDhRWXRaVDBkYUFKMjNrdnB1UjN0MGFBSFFreTE5Y2Zlc0FHazBoWVJmQy1JM1F1RkhDT2Q0SFFnWEp6dnpDQXBmTmJoOVdpVUhWR1hpd3BKTQ?oc=5","date":"2025-09-25","type":"pipeline","source":"Pfizer","summary":"Pfizer Highlights Momentum in Redefining Standards of Care in Cancer at ESMO 2025 - Pfizer","headline":"Pfizer Highlights Momentum in Redefining Standards of Care in Cancer at ESMO 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNbERTUlVGUGVjSzZ0VHVnb1VfZ2JnNjVoVVF2dUhiWlJ6SFZhc3VyZjN0WUU5czJHY2tja0ZUQlJydl8ya0NRMmJ2OTVxck16Qk5WR0FQR3dUb2VYMm4xbURhSDhEamlXQ21SVzlDcGVCMVhLQXYxVUdiS29YM0UwUlc4Z0N0TGl3ai1wSDlaNXZXU3NVV1l2NDNDVng4VE8zeEdmeU5Vc2VMaW9kbE9qX0tn?oc=5","date":"2025-07-18","type":"pipeline","source":"BioSpace","summary":"Prostate Cancer Treatment Market Size to Reach USD 34.28 Billion by 2034 - BioSpace","headline":"Prostate Cancer Treatment Market Size to Reach USD 34.28 Billion by 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQZUZyVU05TDJaNVdEczUtZVhaSk5seTVjYTdQVkV2Q1ppNzhhc0lhOUpJWkpsLVpxaXNZT1M4bF8zUG50YUk2a0JGTUZLRm0yWllJRVo4dHR5eDkwbFk2MnN0TU5IRUxHZXQ4LUZNXzJ5eG5qWXBBNWt6M3poTGhnVWlRSXZ1VVRGVzR2c3F3S0tqUzVaQUZoYzItVmxEZkdwVnJUUERSR01YQkJ0YVp3?oc=5","date":"2025-05-26","type":"pipeline","source":"World Pharmaceutical Frontiers","summary":"Astellas, Pfizer’s Xtandi shows long-term benefits in prostate cancer - World Pharmaceutical Frontiers","headline":"Astellas, Pfizer’s Xtandi shows long-term benefits in prostate cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxPOURmU1lfaUJHZ0FmM0hEeWNoSW5PNlRaZ21nWkFialNhNmFjRW5DdmVNT0FMb21zY3hfbjhHNEZJV1RfZGxxTk1GZ0VOdDFBZ2JzRVRSNjRsN05mLVQ5Ym12QjJ2YmRkVVVza0RoSTB5MkROYndNekZtTEd3VkZ0aGFnZDJ3TXBlTW5MemdkanVXNGZpWkpRTlBjcnBoWjNqNWYxY2JCRDduZUpMcHdoeXI1SEJtYU45V0JxdVRud3AzSzA2QUs4RXdWamp6T3A4SlNMbm1PY0JCZGstTG5MVXhhS1ZVNnM5MzRrdUpJcUpmOXJ4TldsaUVVWUQzcGdvb21nb1BsTHY?oc=5","date":"2025-05-22","type":"pipeline","source":"prnewswire.com","summary":"Astellas and Pfizer's XTANDI™ (enzalutamide) Shows Long-Term Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer - prnewswire.com","headline":"Astellas and Pfizer's XTANDI™ (enzalutamide) Shows Long-Term Overall Survival in Metastatic Hormone-Sensitive Prostate C","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOY1psWGdlazZqVGVwcG9iSExHSGVXbmk5dEE5N1Qyc0hoT0ZTN2tJUnJZQmJsQmI3Q0ZUWXluaXh4TVBkTjhjcWp3NTZQSWhubm1mR0hwTE4ya1l6d0ZMVEsxRFNpSkpmdkZ6bDNDU3dMNnZvdTJkVjdlOVlOZ1VRNnF2dVZfeVZ0LWh0Mzg1NU4zQlVuUEh0MnplZ0tWVmE0YU5LeWFqR1BiQQ?oc=5","date":"2025-04-16","type":"trial","source":"Monash Lens","summary":"Painting a bigger picture: The importance of cultural diversity in clinical trials - Monash Lens","headline":"Painting a bigger picture: The importance of cultural diversity in clinical trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFBHcEdtUjBWbGRMWU5hazVGUXlsR0o2REM2VVJQd25BYkJLOGtHUmNBOVl4TzZnOGl2Q2dOMy1XUFRNamdzNmFjZm9SX0d4RW9uYzZzckxMSmozLUNYZm0ydVJDNVl3aG9uaS1vaXBsY25CNVg2b0w5Y3BNQVVfUQ?oc=5","date":"2025-02-05","type":"trial","source":"Clinical Trials Arena","summary":"RedHill Biopharma launches trial of combination therapy for prostate cancer - Clinical Trials Arena","headline":"RedHill Biopharma launches trial of combination therapy for prostate cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPeXQ1NHZEQ1U0Zy1OVTI2NHlzaDV6alh0a0dBRUVXZmhMM05Rb1hBdG9sanJsTnoyZDFFcHk1SFE3cmFjTU8yTnhrZkhocVlUQmNsWmN3UlpXUk5ieVEzSUtCRXRJakZYd3hKWVRoS1prUEJWb0JKal8tbkU2eFFTNVY5aVJjZWhPSklyT25xOWhoUQ?oc=5","date":"2024-09-17","type":"pipeline","source":"news.med.miami.edu","summary":"Desai Sethi Research Team Identifies How to Reverse the Genetics of Poor Prostate Cancer Outcomes - news.med.miami.edu","headline":"Desai Sethi Research Team Identifies How to Reverse the Genetics of Poor Prostate Cancer Outcomes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTFAwTC1KLUYtYmdjSUtHTVVsQzhzcEhkT2lWN0pEa19xLTBjQXFfclNXUUtlSXYtTUlFQXRXamk3S2gtRGkwVGdkc1FobHJta3YyWTA0SEZfdlIyX3JDZk1tOA?oc=5","date":"2019-06-02","type":"pipeline","source":"NEJM","summary":"Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer - NEJM","headline":"Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}